
Artificial provides an AI-driven platform for life sciences labs, aiming to digitize, orchestrate, and optimize the scientific process. Their solution connects lab instruments, people, and data into a single, scalable system, enabling end-to-end workflow management from design to analysis. Key features include centralized lab control, automated data flow, interactive digital SOPs for manual operations, and continuous monitoring. The platform is cloud-based and offers a Python SDK and REST APIs for connectivity. Artificial's business model likely involves SaaS or licensing for its platform and professional services for implementation and support. The company is building a team of experts in industrial automation, robotics, and life sciences to redefine lab operations and accelerate discovery.

Artificial provides an AI-driven platform for life sciences labs, aiming to digitize, orchestrate, and optimize the scientific process. Their solution connects lab instruments, people, and data into a single, scalable system, enabling end-to-end workflow management from design to analysis. Key features include centralized lab control, automated data flow, interactive digital SOPs for manual operations, and continuous monitoring. The platform is cloud-based and offers a Python SDK and REST APIs for connectivity. Artificial's business model likely involves SaaS or licensing for its platform and professional services for implementation and support. The company is building a team of experts in industrial automation, robotics, and life sciences to redefine lab operations and accelerate discovery.
Headquarters & focus: Palo Alto–based company providing a cloud-native lab orchestration and automation platform for life-science labs
Product highlights: Cloud platform that connects instruments, people, and data; offers digital SOPs, orchestration, APIs, and a Python SDK
Founding year: 2018
Recent funding: Series A of $21.5M closed May 18, 2021 (led by M12)
Headcount (reported): 22
Laboratory automation and workflow orchestration for life-science R&D
2018
Biotechnology
21.5M
Participants included Playground Global and AME Cloud Ventures
“Backed by established corporate and deep-tech investors (M12, Playground Global, AME Cloud Ventures)”